Farnsworth von Cederwald, Anneli
Lilja, Josefine L.
Hentati Isacsson, Nils
Kaldo, Viktor
Funding for this research was provided by:
Linnaeus University
Article History
Received: 18 August 2023
Accepted: 18 October 2023
First Online: 31 October 2023
Declarations
:
: This study was approved by the Swedish Ethical Review Board (reference number 2020–04198) in Uppsala. This study was approved by the Swedish Ethical Review Board (reference number 2020–04198) in Uppsala. The trial is conducted in accordance with all relevant guidelines and regulations, the Declaration of Helsinki, and Good Clinical Practice (GCP). Informed consent is obtained from all participants after written information has been made available and the patient has had the chance to discuss with a research assistant over the phone. The results from the study will be presented so that no individuals, neither patients nor staff, will be identifiable. All results will be presented on a group level. All participation is voluntary, and the participants can withdraw from the study at any time.
: Not applicable.
: The authors declare no competing interests.